MM

Matthew McNamara

Mr McNamara has over 35 years of executive and funds management experience in the healthcare and medical sciences sectorIn 2003, he founded BioBridge Australia, a biotechnology commercialisation advisory company and advised several public biotechnology / investment companies.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AVE
AVE
10/05/2601,666,6663,169,298N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AVE
AVE
25/05/26
Expiry
1,584,650$0.012$19,015Options expired
AVE
AVE
27/05/25
Issued
3,169,298$0.005$15,846Issue of options
AVE
AVE
29/11/24
Expiry
3,993,644$0.004$15,974Options expired
AVE
AVE
22/11/23
Issued
1,666,666$0.006$9,999Issue of securities
AVE
AVE
22/11/23
Issued
2,499,999$0.004$9,999Issue of securities